Biallelic variants in RNU2-2 cause a remarkably frequent developmental and epileptic encephalopathy.
A newly discovered biomarker ratio may help doctors diagnose a severe inherited neurological condition earlier, improving care planning for affected families.
This companion Nature Genetics paper confirms that biallelic RNU2-2 variants cause the most frequent recessive NDD known, manifesting as severe developmental and epileptic encephalopathy. The study identifies decreased U2-2/U2-1 ratio as a potential diagnostic biomarker and shows the recessive form is mechanistically distinct from the dominant RNU2-2 disorder.
What the study was
- Study design
- Genetic association with clinical phenotyping
- Population
- Individuals with unresolved NDDs, DEE
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- Nature Genetics
Why it surfaced
Companion paper delineating clinical phenotype of recessive RNU2-2 syndrome and proposing a diagnostic biomarker (U2-2/U2-1 ratio). Landmark rare disease discovery.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.